David B. Bylund
Impact in
- Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
- Neurotransmitter Receptor Influence on Behavior
- Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Papers in
-
- Neuropeptides and Animal Physiology 25
- Neuroscience and Neuropharmacology Research 22
- Neurotransmitter Receptor Influence on Behavior 11
- Co-authors
- Solomon H. SnyderL. Charles MurrinDavid C. U’PrichardDavid S. MiddlemasSusan B. JonesMyron L. ToewsH. Kevin HappeJeff Sanders
- Journals
- Life Sciences (8 papers)Biochemical Pharmacology (7 papers)European Journal of Pharmacology (5 papers)Psychiatry Research (4 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
David B. Bylund
84 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cellular and Molecular Neuroscience 2.4k
- Behavioral Neuroscience 366
- Biological Psychiatry 152
- Developmental Neuroscience 155
- Molecular Biology 2.3k
Countries citing papers authored by David B. Bylund
This map shows the geographic impact of David B. Bylund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Bylund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Bylund more than expected).
Fields of papers citing papers by David B. Bylund
This network shows the impact of papers produced by David B. Bylund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Bylund. The network helps show where David B. Bylund may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David B. Bylund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 3 | |
| 2 | 2013 | 11 | |
| 3 | 2011 | 25 | |
| 4 | 2008 | 42 | |
| 5 | 2007 | 38 | |
| 6 | 2007 | 172 | |
| 7 | 2007 | 34 | |
| 8 | 2006 | 19 | |
| 9 | 2004 | 5 | |
| 10 | 2004 | 9 | |
| 11 | 2003 | 0 | |
| 12 | 2002 | 10 | |
| 13 | 2002 | 4 | |
| 14 | 2001 | 26 | |
| 15 | 2000 | 19 | |
| 16 | 1998 | 31 | |
| 17 | 1995 | 54 | |
| 18 | 1993 | 18 | |
| 19 | 1993 | 24 | |
| 20 | 1990 | 3 |
About David B. Bylund
David B. Bylund is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Animal Science and Zoology, Molecular Biology and Psychiatry and Mental health, having authored 89 papers that have together received 4.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (50 papers), Neuropeptides and Animal Physiology (25 papers), Neuroscience and Neuropharmacology Research (22 papers), Pharmacological Effects and Assays (14 papers), Neurotransmitter Receptor Influence on Behavior (11 papers), Computational Drug Discovery Methods (7 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.4k citations), Behavioral Neuroscience (366 citations), Biological Psychiatry (152 citations), Developmental Neuroscience (155 citations) and Molecular Biology (2.3k citations). David B. Bylund has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Solomon H. Snyder, L. Charles Murrin, David C. U’Prichard, David S. Middlemas, Susan B. Jones, Myron L. Toews, H. Kevin Happe, Jeff Sanders, S.J. Enna and Leslie L. Iversen. Their work appears in journals such as Life Sciences, Biochemical Pharmacology, European Journal of Pharmacology, Psychiatry Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.